| Literature DB >> 34946725 |
Gulmira Özek1, Igor A Schepetkin2, Moldir Yermagambetova3,4, Temel Özek1,5, Liliya N Kirpotina2, Shyryn S Almerekova3,4, Saule I Abugalieva3,4, Andrei I Khlebnikov6, Mark T Quinn2.
Abstract
Little is known about the immunomodulatory activity of essential oils isolated from Juniperus species. Thus, we isolated essential oils from the cones and leaves of eight juniper species found in Montana and in Kazakhstan, including J. horizontalis, J. scopolorum, J. communis, J. seravschanica, J. sabina, J. pseudosabina, J. pseudosabina subsp. turkestanica, and J. sibirica. We report here the chemical composition and innate immunomodulatory activity of these essential oils. Compositional analysis of the 16 samples of Juniper essential oils revealed similarities and differences between our analyses and those previously reported for essential oils from this species. Our studies represent the first analysis of essential oils isolated from the cones of four of these Juniper species. Several essential oil samples contained high levels of cedrol, which was fairly unique to three Juniper species from Kazakhstan. We found that these essential oils and pure (+)-cedrol induced intracellular Ca2+ mobilization in human neutrophils. Furthermore, pretreatment of human neutrophils and N-formyl peptide receptor 1 and 2 (FPR1 and FPR2) transfected HL60 cells with these essential oils or (+)-cedrol inhibited agonist-induced Ca2+ mobilization, suggesting these responses were desensitized by this pretreatment. In support of this conclusion, pretreatment with essential oils from J. seravschanica cones (containing 16.8% cedrol) or pure (+)-cedrol inhibited human neutrophil chemotaxis to N-formyl peptide. Finally, reverse pharmacophore mapping predicted several potential kinase targets for cedrol. Thus, our studies have identified cedrol as a novel neutrophil agonist that can desensitize cells to subsequent stimulation by N-formyl peptide.Entities:
Keywords: Juniperus; calcium flux; cedrol; chemotaxis; essential oil; neutrophil; sesquiterpene
Mesh:
Substances:
Year: 2021 PMID: 34946725 PMCID: PMC8709035 DOI: 10.3390/molecules26247644
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Location and date of collection of the plant material.
| Locality | Latitude | Longitude | Altitude (m) | Plant Material | Date of Collection | Yield (%) Leaves/Cones | |
|---|---|---|---|---|---|---|---|
| Trans-Ili Alatau, Big Almaty gorge, Almaty region, South-Eastern Kazakhstan | 43.04450° | 76.97850° | 2714 | leaves | July 2019 | 0.5 | |
| Trans-Ili Alatau, Kim-Asar gorge, Almaty region, South-Eastern Kazakhstan | 43.16250° | 77.09388° | 2264 | cones | September 2020 | 0.7 | |
| Trans-Ili Alatau, Big Almaty gorge, Almaty region, South-Eastern Kazakhstan | 43.04450° | 76.97850° | 2714 | leaves | September 2020 | 0.7 | |
| Lineisky Ridge, West Altai Nature Reserve, Eastern Kazakhstan | 49.2544° | 82.5736° | 1589 | cones | August 2020 | 0.8 | |
| Western Tien-Shan, Aksu-Zhabagly Nature Reserve, sublatitudinal crest of the ridge in the region of the Kshi-Kaindy pass, Turkistan region, Southern Kazakhstan | 42.39352° | 70.55950° | 1854 | leaves/cones | July 2020 | 0.4/0.6 | |
| Western Tien-Shan, Mashat gorge, Aksu-Zhabagly Nature Reserve, Turkistan region, Southern Kazakhstan | 42.41652° | 70.20741° | 1005 | leaves/cones | August 2021 | 0.5/0.4 | |
| Trans-Ili Alatau, Kim-Asar gorge, Almaty region, South-Eastern Kazakhstan | 43.16250° | 77.09388° | 2264 | leaves/cones | September 2020 | 1.4/2.0 | |
|
| Bozeman, MT, USA | 45.66885° | 111.06629° | 1462 | leaves/cones | August 2019 | 1.0/1.2 |
|
| Sypes canyon, | 45.74118° | 110.98698° | 1415 | leaves/cones | August 2019 | 1.1/1.0 |
|
| Hyalite Canyon, Bozeman, MT, USA | 45.48873° | 111.00474° | 2142 | leaves/cones | August 2019 | 0.6/1.0 |
Main compound components of essential oils (%) isolated from leaves and cones of different Juniperus species.
| No | RRI | Compound | JHLv | JHCon | JSLv | JSCon | JCLv | JCCon | JSELv | JSECon | JSALv | JSACon | JTLv | JTCon | JPSLv | JPSCon | JSILv | JSICon |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1032 | α-Pinene | 1.2 |
| 1.3 |
|
|
|
|
| 1.2 |
|
|
|
|
|
|
|
| 2 | 1035 | α-Thujene | 0.5 | 1.8 | 1.2 |
| 0.7 | 1.8 | 1.1 | 1.8 | 1.7 | |||||||
| 3 | 1118 | β-Pinene | 0.1 | 0.2 | 0.1 | 0.2 |
| 0.6 | 0.7 | 0.6 | 0.1 | 0.2 | 1.5 | 1.6 |
|
| 1.8 | 1.1 |
| 4 | 1132 | Sabinene |
|
|
|
| 0.4 | 0.2 | 0.2 | 0.4 |
|
|
|
|
|
|
| 0.3 |
| 5 | 1159 | δ-3-Carene |
| t | 0.8 | t | 0.1 | 1.3 | 0.4 | |||||||||
| 6 | 1174 | Myrcene |
|
| 0.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7 | 1188 | α-Terpinene | 0.6 | 0.5 | 1.2 |
| t | 0.1 | 0.1 | 0.3 | 0.3 | 1.5 | 0.3 | 0.7 | 0.6 | 1.3 | ||
| 8 | 1203 | Limonene |
| 1.5 |
|
| 1.2 | 1.2 | 1.0 | 1.2 | 0.8 | 1.0 | 1.8 | |||||
| 9 | 1255 | γ-Terpinene | 1.0 | 0.9 |
|
| t | t | 0.7 | 1 | 0.6 | 0.6 |
| 0.5 | 1.1 | 1.0 |
| t |
| 10 | 1280 | t | 0.1 | 1.1 |
| t | t | 0.9 | 0.2 | 0.4 | 0.1 | 0.2 | 0.6 | 0.4 | 0.2 | 1.1 | t | |
| 11 | 1451 | β-Thujone |
| t | 0.1 | 0.9 | t | 0.1 | 0.1 | 0.4 | ||||||||
| 12 | 1553 | Linalool | 0.2 | 0.6 | 0.1 | 0.1 | 0.1 | 0.6 | 1.3 | 1.0 | 1.8 |
| 0.1 |
| 0.3 | 1.0 | ||
| 13 | 1579 | Pregeijerene B | 0.1 |
| 0.2 | |||||||||||||
| 14 | 1590 | Bornyl acetate |
| t | 0.1 | t | 0.6 | 0.3 | 0.7 | 1.2 | 0.1 | t | 0.1 | 0.1 | t | 0.4 | 0.2 | 0.4 |
| 15 | 1611 | Terpinen-4-ol |
|
|
|
| 0.1 | 0.2 | 0.5 | 1.3 |
| 1.5 |
|
|
|
|
| 0.8 |
| 16 | 1658 | Sabinyl acetate |
| t |
| 1.0 | t | t | ||||||||||
| 17 | 1709 | α-Terpinyl acetate | 0.2 | 0.2 | 0.3 | 0.4 |
| 0.7 | ||||||||||
| 18 | 1726 | Germacrene D | 0.2 | 0.6 | 0.1 | 0.6 |
|
| 0.1 | 0.9 | 0.1 | 0.2 | 0.4 | 0.4 |
| |||
| 19 | 1773 | δ-Cadinene | 0.9 | 0.1 | 0.8 | 0.3 | 0.4 | 0.7 | 0.3 | 0.2 | 0.1 | t | 0.7 | 0.1 | 0.6 | 1 | 0.8 |
|
| 20 | 2069 | 1,6-Germacradien-5β-ol | 0.7 | 0.5 | 1.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.7 | 0.3 | 0.7 | 1.4 | 0.8 |
| |||
| 21 | 2096 | Elemol |
| 0.1 |
|
| 0.5 |
| 1.3 |
| 1.2 | 0.7 | 0.3 | |||||
| 22 | 2143 | Cedrol |
|
|
| 1.0 | t |
|
| |||||||||
| 23 | 2479 | 8-α-Acetoxyelemol | 0.1 |
| 1.0 | t | t | |||||||||||
| 24 | 2492 | 8,13-Abietadiene | 0.1 | 0.1 | 0.4 | 0.1 |
| 0.2 | 0.4 | 0.1 | 0.4 | t |
The data are presented as relative % for each component that was identified in the essential oils. RRI, relative retention index calculated on the basis of retention of n-alkanes; %, calculated from flame ionization detector data. Trace amounts (t) were present at <0.1%. All other compounds were identified by comparison with co-injected standards. Major component compounds (>2%) are indicated in bold. Abbreviations: JHLv, J. horizontalis leaves; JHCon, J. horizontalis cones; JSLv, J. scopolorum leaves; JSCon, J. scopolorum cones; JCLv, J. communis leaves; JCCon, J. communis cones; JSELv, J. seravschanica leaves; JSECon, J. seravschanica cones; JSALv, J. sabina leaves; JSACon, J. sabina cones; JTLv; J. pseudosabina subsp. turkestanica leaves; JTCon, J. pseudosabina subsp. turkestanica cones; JPSLv, J. pseudosabina leaves; JPSCon, J. pseudosabina cones; JSILv, J. sibirica leaves; JSICon, J. sibirica cones.
Summary of the chemical composition (%) of essential oils from Juniperus species.
| Compounds | JHLv | JHCon | JSLv | JSCon | JCLv | JCCon | JSELv | JSECon | JSALv | JSACon | JTLv | JTCon | JPSLv | JPSCon | JSILv | JSICon |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monoterpene hydrocarbons | 37.8 | 91.9 | 85.0 | 59.6 | 84.9 | 77.9 | 72.0 | 62.2 | 41.0 | 89.4 | 68 | 91.1 | 59.3 | 82.3 | 68.6 | 50.3 |
| Oxygenated monoterpenes | 51.8 | 6.4 | 13.3 | 28.5 | 4.8 | 4.9 | 4.4 | 3.2 | 42.6 | 7.0 | 20.1 | 4.4 | 20.2 | 4.6 | 23.0 | 2.2 |
| Sesquiterpene hydrocarbons | 1.5 | 0.9 | 1.4 | 1.2 | 7.3 | 14.6 | 6.9 | 7.0 | 1.5 | 0.6 | 1.2 | 0.9 | 1.9 | 3.7 | 3.2 | 33.5 |
| Oxygenated sesquiterpenes | 5.1 | 0.1 | 32.6 | 9.0 | 1.7 | 1.9 | 13.7 | 18.1 | 12.5 | 1.2 | 6.4 | 2.7 | 14.0 | 8.5 | 3.9 | 12.9 |
| All sesquiterpenes | 6.6 | 1.0 | 34.0 | 10.2 | 9.0 | 16.5 | 20.6 | 25.0 | 14.0 | 1.8 | 7.6 | 3.6 | 15.9 | 12.2 | 7.1 | 46.4 |
| Diterpenes | 0.5 | 0.1 | 0.4 | 0.4 | 0.1 | 5.4 | 0.4 | 0.4 | 0.1 | 0.6 | 0.2 | |||||
| Fatty acids | 0.2 | 0.2 | 0.1 | 0.1 | 0.8 | 0.1 | 0.2 | |||||||||
| Others | 0.1 | 2.2 | 0.2 | 0.4 | 0.1 | 0.3 | 0.1 | 2.7 | 0.3 | 1.7 | 0.2 | 0.1 | ||||
| Total | 96.7 | 99.5 | 96.9 | 98.9 | 98.9 | 99.5 | 97.4 | 95.9 | 98.3 | 98.3 | 98.9 | 99.6 | 98.5 | 99.4 | 99.0 | 99.1 |
Abbreviations: JHLv, J. horizontalis leaves; JHCon, J. horizontalis cones; JSLv, J. scopolorum leaves; JSCon, J. scopolorum cones; JCLv, J. communis leaves; JCCon, J. communis cones; JSELv, J. seravschanica leaves; JSECon, J. seravschanica cones; JSALv, J. sabina leaves; JSACon, J. sabina cones; JTLv; J. pseudosabina subsp. turkestanica leaves; JTCon, J. pseudosabina subsp. turkestanica cones; JPSLv, J. pseudosabina leaves; JPSCon, J. pseudosabina cones; JSILv, J. sibirica leaves; JSICon, J. sibirica cones.
Figure 1(+)-Cedrol induces neutrophil Ca2+ mobilization. Human neutrophils were treated with 25 µM (+)-cedrol, 5 nM fMLF (positive control), or 1% DMSO (negative control), and [Ca2+]i was monitored for the indicated times (arrow indicates when treatments were added). The data are from one experiment that is representative of three independent experiments.
Biological activity of essential oils isolated from leaves and cones of different Juniperus species, as well as pure cedrol.
| Source of | EO | Neutrophils | HL-60-FPR1 | HL-60-FPR2 | Neutrophils |
|---|---|---|---|---|---|
| EC50 (μM) | IC50 (μM) | ||||
| JHLv | 24.7 ± 6.2 | 11.8 ± 3.7 | 10.1 ± 2.4 | 13.8 ± 1.3 | |
| JHCon | 49.8 ± 12.1 | 13.8 ± 4.4 | 18.7 ± 6.4 | N.A. | |
| JSCLv | 24.8 ± 8.4 | 12.7 ± 3.6 | 12.8 ± 3.8 | 16.0 ± 2.9 | |
| JSCon | 38.0 ± 9.4 | 12.1 ± 5.1 | 12.4 ± 4.5 | 27.9 ± 1.4 | |
| JCLv | 54.0 ± 3.5 | 10.1 ± 3.4 | 11.0 ± 4.5 | 34.7 ± 6.4 | |
| JCCon | 53.6 ± 1.9 | 13.6 ± 5.2 | 14.8 ± 4.3 | 29.2 ± 8.0 | |
| JSELv | 43.0 ± 7.7 | 11.6 ± 4.1 | 13.4 ± 3.5 | 35.5 ± 3.8 | |
| JSECon | 41.0 ± 7.1 | 16.0 ± 5.2 | 20.1 ± 6.8 | 34.2 ± 7.9 | |
| JSALv | 28.5 ± 9.3 | 13.6 ± 4.4 | 13.5 ± 4.2 | 23.6 ± 3.3 | |
| JSACon | 40.7 ± 4.3 | 11.8 ± 4.3 | 14.1 ± 2.5 | 35.0 ± 7.6 | |
| JTLv | 43.0 ± 10.1 | 15.6 ± 5.5 | 15.4 ± 2.2 | 36.7 ± 10.8 | |
| JTCon | 13.9 ± 4.2 | 14.1 ± 5.1 | 14.2 ± 2.8 | 29.7 ± 5.3 | |
| JPSLv | 43.5 ± 10.6 | 11.3 ± 4.4 | 12.0 ± 4.1 | 29.4 ± 10.2 | |
| JPSCon | 45.1 ± 9.7 | 14.9 ± 5.4 | 15.1 ± 4.2 | 36.5 ± 11.1 | |
| JSILv | 34.3 ± 7.3 | 7.0 ± 2.3 | 16.5 ± 6.7 | 48.7 ± 8.2 | |
| JSICon | 31.8 ± 3.8 | 10.2 ± 3.5 | 16.4 ± 4.9 | 20.3 ± 6.8 | |
| Cedrol | 15.6 ± 2.5 | 54.0 ± 3.5 | 14.3 ± 3.5 | 15.4 ± 4.3 | |
Figure 2Chemical structure of (+)-cedrol.
Figure 3Inhibition of fMLF-induced neutrophil Ca2+ mobilization by (+)-cedrol. Human neutrophils were treated with the indicated concentrations of (+)-cedrol or 1% DMSO (negative control) for 10 min. The cells were activated by 5 nM fMLF, and [Ca2+]i was monitored, as described. The data are from one experiment that is representative of three independent experiments.
Figure 4Inhibition of neutrophil chemotaxis by essential oil J. seravschanica cones (JSECon) (A) and (+)-cedrol (B). Neutrophil migration toward 1 nM fMLF was measured, as described under Materials and Methods. The data are from one experiment that is representative of two independent experiments.
Figure 5Cytotoxicity of Juniperus essential oils and cedrol. HL60 cells were preincubated with 25 µg/mL of Juniper oil or 25 and 50 µM of pure (+)-cedrol for 30 min (A) and 90 min (B) and cell viability was analyzed, as described. Values are the mean ± SD of triplicate samples from one experiment that is representative of two independent experiments with similar results.
Potential protein targets of (+)-cedrol identified by PharmMapper.
| Rank | PDB ID | Target Name | Fit Score | Rank | PDB ID | Target Name | Fit Score |
|---|---|---|---|---|---|---|---|
|
| 1REU | BMP2 | 1 | 11 | 2PIR | Androgen receptor | 0.8213 |
|
| 1P49 | Steroid sulfatase | 1 | 12 | 3BL1 | CA2 | 0.8032 |
|
| 1J96 | AKR1C2 | 1 | 13 | 3CJG | VEGFR2 | 0.7553 |
|
| 1E7E | Serum albumin | 1 | 14 | 2OF0 | β-Secretase 1 | 0.75 |
|
| 1L6L | Apo A-II | 1 | 15 | 1SQN | Progesterone receptor | 0.75 |
|
| 1W8L | PPIase A | 0.9633 | 16 | 2G01 | JNK1 | 0.7472 |
|
| 2PG2 | KIF11 | 0.9482 | 17 | 1ZXC | ADAM 17 | 0.7442 |
|
| 2C3I | Pim-1 | 0.8963 | 18 | 1SHL | Caspase-7 | 0.7399 |
|
| 1J78 | DBP | 0.8598 | 19 | 1P0P | Cholinesterase | 0.7331 |
|
| 3EQM | P450 19A1 | 0.8397 | 20 | 1S95 | PPP5 | 0.7326 |
Abbreviations: ADAM 17, metalloprotease 17; AKR1C2, aldo-keto reductase family 1 member C2 (bile acid binding protein); Apo A-II, apolipoprotein A-II; BMP2, bone morphogenetic protein 2; CA2, carbonic anhydrase 2; DBP, vitamin D-binding protein; KIF11, kinesin-like protein; JNK1, c-Jun N-terminal kinase 1; P450 19A1, cytochrome P450 19A1; Pim-1, proto-oncogene serine/threonine-protein kinase; PPIase A, peptidyl-prolyl cis-trans isomerase A; PPP5, serine/threonine-protein phosphatase 5; VEGFR2, vascular endothelial growth factor receptor 2.
Predicted physicochemical properties of (+)-cedrol according to SwissADME results.
| Molecular Descriptor | Property |
|---|---|
| Formula | C15H26O |
| M.W. | 222.37 |
| Heavy atoms | 16 |
| Fraction Csp3 | 1.00 |
| Rotatable bonds | 0 |
| H-bond acceptors | 1 |
| H-bond donors | 1 |
| MR | 68.56 |
| tPSA | 20.23 |
| iLogP | 2.99 |
| BBB permeation | Yes |
Abbreviations: M.W., molecular weight (g/mol); MR, molar refractivity; tPSA, topological polar surface area (Å2); iLogP, lipophilicity; BBB, blood–brain barrier.
Figure 6Bioavailability radar plot of (+)-cedrol. The plot depicts the LIPO (lipophilicity), SIZE (molecular weight), POLAR (polarity), INSOLU (insolubility), INSATU (unsaturation), and FLEX (rotatable bond flexibility) parameters.